indobufen
Sign in to saveIndobufen is a platelet aggregation inhibitor. It acts as a reversible cyclooxygenase inhibitor.
Research
235 papers- Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point-Blinded, Noninferiority Trial.Circulation · 2023
- Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis.Vascular pharmacology · 2025
- Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial.The Lancet. Neurology · 2023
- Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome.BMC cardiovascular disorders · 2025
- Indobufen: an updated review of its use in the management of atherothrombosis.Drugs & aging · 2001
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Indobufen is a platelet aggregation inhibitor. It acts as a reversible cyclooxygenase inhibitor.
== References ==
Excerpted from Wikipedia’s “indobufen” article, available under the CC BY-SA 4.0 licence.
Available in 7 languages
via Wikidata sitelinks · CC0